Marrone Bio Innovations, Inc. (NASDAQ:MBII – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,360,000 shares, an increase of 31.1% from the April 15th total of 1,800,000 shares. Approximately 2.5% of the shares of the stock are […]
Marrone Bio Innovations (NASDAQ:MBII – Get Rating) released its earnings results on Wednesday. The basic materials company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02), MarketWatch Earnings reports. Marrone Bio Innovations had a negative return on equity of 65.95% and a negative net margin of 47.07%. During […]
Marrone Bio Innovations, Inc. (NASDAQ:MBII – Get Rating) has earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target […]
StockNews.com started coverage on shares of Marrone Bio Innovations (NASDAQ:MBII – Get Rating) in a report issued on Saturday. The firm set a “sell” rating on the basic materials company’s stock. Other equities analysts also recently issued research reports about the company. Canaccord Genuity Group downgraded Marrone Bio Innovations from a “buy” rating to a […]
Marrone Bio Innovations, Inc. (NASDAQ:MBII – Get Rating) Director Pamela G. Marrone sold 22,728 shares of the stock in a transaction on Thursday, March 24th. The shares were sold at an average price of $1.11, for a total transaction of $25,228.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which […]